Keywords: sankyo, loser, after, troglitazone, pulled, usa, japan

Sankyo the loser after troglitazone is pulled in USA and Japan

Article | 03 April 2000

Print This

The recent withdrawal in the USA and Japan of the troubled antidiabeticdrug Noscal (troglitazone; Marketletter March 27) is more likely to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in